The natural stack
GLP-1 receptor agonists work, but they’re not for everyone. Cost, access, side effects, or personal preference may make you look for alternatives.
There are evidence-based options that work through similar pathways (berberine, inositol) plus emerging peptide therapies that offer different advantages.
But here’s the critical part: understanding GLP-1 rebound is just as important as starting. And if you’re considering peptide therapy as an alternative, knowing what’s proven matters.